LABU
Direxion Daily S&P Biotech Bull 3X Shares [LABU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
LABU Stock Summary
Top 10 Correlated ETFs
LABU
Top 10 Correlated Stocks
LABU
In the News
LABU: A Levered ETF Doomed From The Start
The Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU) is a high-risk, leveraged ETF that aims to yield three times the performance of the S&P Biotechnology Select Industry Index. The biotech sector is known for its volatility, which can significantly impact the performance of LABU. Trading LABU is challenging due to the unpredictable nature of the biotech sector and the path dependence of leveraged ETFs. Investors should use caution and consider alternative investment options.
10 Most-Heavily Traded ETFs of the Last Three Months
High trading volume indicates high liquidity, which is a key characteristic of ETFs.
LABU: 2 Requirements For Making Money In This Leveraged Biotech Fund
LABU is a 3X leveraged fund that has disappointed the biotech bulls. The sector looks beaten and perhaps cheap relative to long-term prospects. LABU can work for medium term returns if two requirements are met.
Top Performing Leveraged/Inverse ETFs: 05/07/2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
5 Leveraged/Inverse ETFs That Gained Double Digits in April
The month of April was marked by huge volatility. Though recession fears continued to weigh on investors sentiment, cooling inflation and better-than-expected earnings drove the stocks higher.
5 Best Inverse/Leveraged ETFs of Last Week
Wall Street offered a flat performance last week.
Leveraged Biotech ETFs: Hold LABU, Sell LABD
SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, the 3X leveraged Biotech ETF, is rated as a HOLD.
Want Diversified Upside in Biotechnology? Check out LABU
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. This ETF attempts to mimic 3X the one-day performance of the SPDR S&P 500 Biotech ETF (NYSE: XBI).
LABU: Leveraged Biotech ETF Review
Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap and small-cap biopharma.
Top Performing Leveraged/Inverse ETFs: 12/04/2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
LABU Financial details
LABU Financial Performance
LABU Frequently Asked Questions
What is Direxion Daily S&P Biotech Bull 3X Shares stock symbol ?
Direxion Daily S&P Biotech Bull 3X Shares is a US stock and trading under the symbol LABU
What is Direxion Daily S&P Biotech Bull 3X Shares stock quote today ?
Direxion Daily S&P Biotech Bull 3X Shares stock price is $3.8801 today.
Is Direxion Daily S&P Biotech Bull 3X Shares stock public?
Yes, Direxion Daily S&P Biotech Bull 3X Shares is a publicly traded company.
Company Profile
- Volume Average 28.43M
- Headquarters US
- IPO Date 2015-05-28
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
